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Summary
M proteins that define the serotypes of group A streptococci are powerful blastogens for human
T lymphocytes. The mechanism by which they activate T cells was investigated and compared
with the conventional T cell mitogen phytohemagglutinin, and the known superantigen staph-
ylococcal enterotoxin B. Although major histocompatibility complex (MHC) class II molecules
are required for presentation, there is no MHC restriction, since allogeneic class II molecules pre-
sented the bacterial protein to human T cells. Type 5 M protein appears to bind class II molecules
on the antigen-presenting cells and stimulate T cells bearing VS 8 sequences. Our results indicate
that this streptococcal M protein is a superantigen and suggest a possible mechanism of its role
in the pathogenesis of the postinfectious autoimmune sequelae.
nfection with group A streptococci may evoke autoimmune
diseases in the susceptible host that can affect the heart,
kidney, or brain (1). The major virulence factor of these or-
ganisms appears to be the surface antigen M proteins, which
are a family of closely related proteins emanating from the
cell surface as ct helical coiled coil fibrils (2). A number of
studies have shown that purified streptococcal M proteins
stimulate nonimmune human T cells to undergo brisk prolifer-
ation (3-6, and Kotb et al., manuscript submitted for publica-
tion). In contrast, synthetic peptides, up to 35 amino acids
in length, copying various regions of the M protein, had no
stimulatory effect. These studies suggested that M protein
did not activate human T cells via classical T cell epitopes
described for conventional antigens. Because of its effect on
such large populations of T cells, M protein may be a super-
antigen (7), requiring larger domains of the protein to as-
sociate with class II MHC molecules and subsequent recog-
nition by the TCR. To test this hypothesis, we conducted
the following study to investigate the possible superantigenic
properties of M protein.
Materials and Methods
Isolation and Purification ofM Protein.
￿
M protein was purified
by limited pepsin digestion of type 5 group A streptococci as de-
scribed (5); the purified fragment is designated pep M5. Staphy-
lococcal enterotoxin B (SEB) was from Sigma Chemical Co. (St.
Louis, MO).
Isolation ofLymphocytes.
￿
PBMC were isolated from heparinized
blood of a number of donors by Ficoll-Hypaque density gradient
centrifugation (5). PBMC were further purified into TandB lym-
phocyte-enriched populations by twocycles ofErosetting (8), fol-
lowed by overnight adherence of both populations at 37°C and
5% COZ in RPMI 1640, 10% FCS, 2 MM L-glutamine, 50 U/ml
penicillin, and 50 hg/ml streptomycin (RPMI complete).
Lymphocyte Culturesfor Assessment ofT Cell Proliferation.
￿
PBMC
(2 x 105), or T cells (101) along with 101 irradiated B cells (3,000
rad), were incubated for 3 d (37°C, 95% humidity, and 5% CO2)
with the indicatedstimuli, and then proliferation was assessed by
['H]thymidine uptake as previously described (5).
mAbs.
￿
Hybridomas secreting anti-HLA-DRantibodies (L243),
anti-HLA-DR, -DQ(9.3 F10),were purchasedfrom American Type
Culture Collection (Rockville, MD) and purified over a protein
A-sepharose column (Sigma Chemical Co.). Purified mAbs to a
humanHLA-A,B,Cwere from Cappel Laboratories (Malvern, PA).
ThemAbs to Vo 5,6,8, and 12 were a generous gift from Dr. J.-C.
Cerottini(LudwigInstitute forCancer Research, Epalinges, Swit-
zerland).
Transfected Mouse Fibroblasts.
￿
Mousefibroblasts transfected with
neomycin resistance gene only (L66), HLA-DR4:Dw14 (L165.1),
HLA-DQ7a:DQw30 (L54.5), or HLA-DPw4a:DPw40 (L25.4)
were a generous gift of Dr. Robert Karr, Iowa City, IA. These
cellswere maintained in theappropriate selectionmedium (DMEM;
Gibco Laboratories, Grand Island, NY) containing 5 x 10-1 M
2-ME, 10% FCS, penicillin, streptomycin, 2 MM. L-glutamine, and
0.25 mg/mlofG418 (Gibco Laboratories) as adherent lines in sterile
tissue culture flasks. To assess their APC function, the cells were
treated with 100 hg/ml mitomycin C for 1 h at 37°C, and then
were added at 2 x 10"/well to purified T cells.
Binding oflip MS to HLA Class II* Cells.
￿
Pep M5 (0.5 mg)
in PBS (pH 7.2)was mixedwith a20-fold molar excess of biotin-
X-NHS (Bio-Rad Laboratories, Richmond, CA) for 4 h at 25°C,
dialyzed overnight against threechangesof PBS (pH7.2), and then
filter sterilized. Purified T or B cells were incubated for 30 min
with or without5Ag/ml biotinylated pep M5,washed repeatedly,
and incubated for 30 min with 50 Al (1:10 dilution) of FITC-
conjugated avidin (Sigma Chemical Co.), and then analyzed using
an Epics 753 dye-laser flow cytometer (Coulter Electronics Inc.,
Hialeah, FL) (5).
359
￿
The Journal of Experimental Medicine " Volume 172
￿
July 1990
￿
359-362Results and Discussion
Pep M5 was used to stimulate highly purified human pe-
ripheral T cells in the presence or absence of accessory cells
(AC) . Although we previously showed that pep M5-induced
T cell proliferation is AC dependent, the role of these cells
in the response was not clear (4) . Most antigens are processed
by theAC and presented to theT cells in the context ofMHC
elements ; whereas, mitogens require AC only to provide a
solid matrix for crosslinking-relevant T cell surface molecules .
To distinguish between these possibilities, we tested the pre-
sentation requirements forM protein. Unlike PHA, bothM
protein- and SEB-induced T cell stimulation require the ex-
pression of class II molecules by APC . AC lacking class 11
molecules, such as U937 cells andhuman foreskin fibroblasts,
were ineffective in presenting pep M5 to T lymphocytes (data
not shown) . Because these observations suggested that pep
M5 may associate directly with class II molecules, we asked
if antibodies to these molecules would interfere with this as-
sociation. Monoclonal anti-HLADR and anti-HLADR, DQ
inhibited the response of human T lymphocytes to pep M5
and to the known superantigen, SEB, but had little effect
on the response to PHA (Fig. 1) .
These results suggested that class 11 antigens are required
for the presentation of pep M5 . Despite this requirement,
the presentation of pep M5 to T cells does not appear to be
MHC restricted, since allogeneic cells were as effective as au-
tologous cells in supporting human T cell proliferation in
response to pep M5 (Table 1) . The lack ofMHC restriction
was further shown in experiments where mouseL cells, trans-
fected and expressing high densities of both HLA class II
a and 0 chains, were used as APC . Fibroblasts transfected
withHLADR, -DQ, and-DP were all capable of presenting
pep M5 and SEB to purified human T lymphocytes . In con-
trast, fibroblasts transfected with the neomycin resistance gene
Figure 1.
￿
Inhibition of pep M5-induced T cell proliferation by
anti-HLA class II antibodies . PBMC were stimulated with 5 hg/ml
pep M5 or PHA, or 1 pg/ml SEB. Monoclonal anti-HLA-DR, and
-HLA-DR, -DQ were added to the cultures, as indicated, at 12 jig
protein/culture . Proliferation was assessed after 3 d by measuring
[3H]thymidine uptake. In the absence of either stimulants or anti-
bodies, uptake values were 3.8 and 3.9 for each experiment, and in
the presence of anti-HLA antibodies, these values were 2.6 and 2.4,
respectively . To control for nonspecific inhibition, we used a similarly
purified monoclonal anti-S-adenosylmethionine synthetase that had no
significant inhibitory effect on either pep M5 or SEB stimulation .
Results are representative of two different experiments, each was
repeated at least three times with cells from various individuals . Inhi-
bition was also observed with antibody concentrations of 15, 6, and
3 ug protein/culture .
360 Superantigenicity of Streptococcal M Protein
Table 1 .
￿
MHC Nonrestricted Presentation of Pep MS by APC
Purified T cells (105) were incubated with 105 irradiated autologous
or allogeneic B cells in the presence or absence of 5 F&g/ml pep M5 .
Proliferation was assessed after 3 d by [3H]thymidine uptake. Exps .
1 and 2 were conducted using T cell clones, whereas in experiments
3 and 4 freshly purified T cells were used .
alone (L66) did not present pep M5 or SEB, but did provide
the necessary component(s) for stimulation by PHA (Fig.
2 A) . Once again, antibodies to either HLADR orHLA
DR, -DQ inhibited the presentation ofM protein and SEB
but did not significantly affect that induced by PHA (Fig.
2 B) . Our results suggest thatM protein is neither a conven-
tional antigen restricted byMHC elements, nor is it a typ-
ical mitogen, since class II-positive cells are required for its
presentation to T cells.
Although the above data strongly suggest that pep M5
interacts with class 11 molecules, it was important to deter-
mine ifwe could detect physical binding between these mol-
ecules . To this end, biotinylated pep M5 was incubated with
either purified T or B cells, and the binding was visualized
using FITC-avidin and analyzed by flow cytometry . T cells
were incapable of binding pepM5 (data not shown) . As seen
in Fig . 3, pep M5 bound avidly to B cells and, furthermore,
this binding was reduced in the presence of either unbio-
tinylated pep M5 or anti-HLADR antibodies, but not by
SEB, which also binds class 11 molecules (9-12, and our un-
published data) . This is not surprising since SEB and pep
M5 could be binding class 11 molecules at two distinct sites.
Alternatively, pep M5 could bebinding with a higher affinity
than SEB, which would be analogous to previous observa-
tions showing that SEA can inhibit the binding of SEB to
class II molecules but not vice versa (10) . Antibodies to class
I molecules were ineffective in competing for binding ofbio-
tinylated pep M5 to B cells (data not shown) .
The superantigens described so far appear to interact with
the human TC (ct/0) receptor via a specific set of V0 ele-
ments (13-16) . To determine ifT cell stimulation by pep M5
is V(3 specific, we analyzed the pepM5- and anti-CD3-stim-
Exp . Donor APC
[ 3H]Thymidine uptake
-Pep M5 +Pep M5
cpm x 10-1 ± SEM
1 Autologous 0.3 ± 0.04 17.2 ± 1.0
Allogeneic 0.6 ± 0.2 11 .0 ± 1.0
2 Autologous 1 .2 ± 0.4 7.8 ± 0.3
Allogeneic 0.8 ± 0.04 11 .8 ± 0.7
3 Autologous 2.0 ± 0.3 35.0 ± 1 .6
Allogeneic 6 .0 ± 0.8 17.0 ± 1 .4
4 Autologous 0.4 ± 0.1 7.6 ± 0.5
Allogeneic 0.2 ± 0.1 5.0 ± 0.4Log Fluorescence
A
Figure 3 .
￿
Binding of pep M5 to HLA class 11-positive cells.
Purified T or B cells were incubated for 30 min with or without 5
wg/ml biotinylated pep M5 . The cells were washed repeatedly and in-
cubated for 30 min with 50 A1 (1:10 dilution) of FITC-conjugated
avidin . Background nonspecific fluorescence was detected in groups
where FITC-labeled avidin was added alone and was subtracted from
both the control (bold line) and the inhibited (thin line) values. The
cells were analyzed by flow cytometry, and the data are representative
of a series of three separate experiments . To control for nonspecific
fluorescence, we tested the ability of various agents to compete for
the binding by biotinylated pep M5 : (A) competition with 50 Ag un-
labeled pep M5 ; (B) competition with 25 Kg unlabeled SEB ; and (C)
competition with mAb (6 ug protein) to HLA-DR . It should be
noted that EBVtransformed B cells as well as transfected fibroblasts
expressing HLA-DR, -DP, or -DQ bound pep M5, whereas cells
from the human leukemic T cell line Jurkat were ineffective in this
capacity (data not shown). This binding was also inhibited by unbi-
otinylated pep M5 .
ulated blast cells for expression ofV0 5, 6, 8, or 12 by flow
cytometry . A significant expansion of V,(3 8-bearing T cells
was observed (Table 2), but due to the limitedmAbs to specific
Vos, it was not possible to determine if other V0 elements
were also expanded . We have recently adopted the technique
of Choi et al . (16), using PCR and specific primers to the
various V0 families . Preliminary experiments confirm the
usage ofV0 8 and indicate the usage of a set ofadditional V,Qs .
Based on the above findings, we propose that streptococcal
M protein is a superantigen, resembling anumber of staphy-
lococcal toxins (7, 15, 16) and a soluble product secreted by
mycoplasma arthritidis (17) . Marrack, Kappler, and colleagues
(7) have suggested a role for superantigens in the develop-
ment ofautoimmune disorders, and various enterotoxins have
been implicated in this respect. It is wellknown that autoim-
mune disorders such as rheumatic heart disease and glo-
merulonephritismay occur after infection with groupA strep-
tococci . Our thinking for some time has been that these
autoimmune diseases may be the result of molecular mim-
Table 2 .
￿
V,Bspecifc Stimulation ofHuman T Cells by Pep MS
Stimulus
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Anti-CD3
Pep M5
SEB
Figure 2 .
￿
Presentation of pep M5 by HLA class
II-transfected mouse fibroblasts . T cells (105) were
cultured with or without 2 x 10° mitomycin
C-treated mouse fibroblasts transfected with neo-
mycin resistance gene only (L66), HLA-DR
(L165 .1), HLA-DQ (L54 .5), or HLA-DP(L25 .4).
(A) Cultures were incubated for 3 d in medium
alone or in the presence of pep M5 (5 FAg/ml),
PHA (5 Fcg/ml), or SEB (1 Fig/ml) . Proliferation
was assessed by [3Hithymidine incorporation . The
data are representative of a series of five experiments
and are expressed as the mean of triplicate cultures
f SEM . (B) Purified monoclonal anti-DR, or anti-
DR, -DQ were included in the culture, as indicated
above, at 6 Fcg protein/well. The data represent one
of three experiments and show typical results. In B,
L66 (Neo only) did not present pep M5 or SEB,
while supporting the response to PHA with uptake
values of 41.5 and 47 in the absence and presence of
anti HLA-DR, respectively .
V05 V06 V08 V1312 CD3
3.4 3.2 6 .4 4.5 96.9
3.1 2.1 2.9 1.9 96.0
2.5 2.2 15.4 3.1 98.3
4.1 3.6 2 .5 5.0 97 .3
T cells (106) and 5 x 105 irradiated autologous B cells were incubat-
ed in RPMI complete medium for 3 d in the presence or absence of
1 pg/ml pep M5, 10 u1 anti-CD3 antibody, or 1 ag/ml SEB . After
incubation, the cells were cultured for an additional 24 h in medium
containing IL-2 to allow regeneration of potentially modulated
receptors . Specific V(3 expression was determined using mAbs and
indirect immunofluorescence. Analysis was performed using flow
cytometry, gating on the large blasted cells .icry betweenthe M protein and host tissue proteins, andthat
humoral immunity may be involved in this process. Based
on our new findings, our views may need to be modified to
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